Benalaxyl-M

Suppliers

Names

[ Name ]:
Benalaxyl-M

[Synonym ]:
kiralaxyl
(-)-(R)-methyl N-(phenylacetyl)-N-(2,6-xylyl)alaninate
methyl N-(phenylacetyl)-N-(2,6-xylyl)-D-alaninate
methyl (2R)-2-(2,6-dimethyl-N-(2-phenylacetyl)anilino)propanoate
chiralaxyl
(R)-2-[(2,6-dimethyl-phenyl)-phenylacetyl-amino]-propionic acid methyl ester
methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-D-alaninate
Kiralaxyl
Benalaxyl-M [ISO]
Benalaxyl-M
D-Benalaxyl
(-)-R-Benalaxyl

Chemical & Physical Properties

[ Density]:
1.131g/cm3

[ Boiling Point ]:
468.8ºC at 760mmHg

[ Molecular Formula ]:
C₂₀H₂₃NO₃

[ Molecular Weight ]:
325.40200

[ Flash Point ]:
237.3ºC

[ Exact Mass ]:
325.16800

[ PSA ]:
46.61000

[ LogP ]:
3.44060

[ Index of Refraction ]:
1.574

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves

[ Hazard Codes ]:
N

[ Risk Phrases ]:
51/53

[ Safety Phrases ]:
61

[ RIDADR ]:
UN3077 9/PG 3

[ HS Code ]:
2924299090

Customs

[ HS Code ]: 2924299090

[ Summary ]:
2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Articles

High-throughput electrophoretic mobility shift assays for quantitative analysis of molecular binding reactions.

Anal. Chem. 86(20) , 10357-64, (2014)

We describe a platform for high-throughput electrophoretic mobility shift assays (EMSAs) for identification and characterization of molecular binding reactions. A photopatterned free-standing polyacry...

Formulation approaches to improving the delivery of an antiviral drug with activity against seasonal flu.

Pharm. Dev. Technol. 20(2) , 169-75, (2015)

The main objective of the present study was to develop formulations of noscapine hydrochloride hydrate with enhanced solubility and bioavailability using co-solvent- and cyclodextrin-based approaches....

Purification and characterization of a DNA-binding recombinant PREP1:PBX1 complex.

PLoS ONE 10(4) , e0125789, (2015)

Human PREP1 and PBX1 are homeodomain transcriptional factors, whose biochemical and structural characterization has not yet been fully described. Expression of full-length recombinant PREP1 (47.6 kDa)...

3-(m-aminophenyl)-N-(4-chloro-2,5-dimethoxyphenyl)-3-oxopropionamide
1-(m-chlorophenyl)-1,2-cyclopropanedicarboximide
N-m-methylphenyl-S-methylisothiazolidinium tetraphenylborate
3-m-Tolyl-isoxazol-5-ylamine
1-M-TOLYLAMINOCYCLOHEXANECARBOXYLICACID
(S)-M-METHYL-A-PHENYLETHYLAMINE
5-bromo-2-(tetrahydro-3-furanyl)Benzothiazole
3-Tert-butyl-6-[4-(4,4-difluoropiperidine-1-carbonyl)piperidin-1-yl]pyridazine
tert-butyl (2-methyl-5-(1-methyl-1H-pyrazol-5-yl)-5-oxopentyl)carbamate
tert-butyl (3R)-3-[(propylamino)methyl]piperidine-1-carboxylate
5-bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-Thieno[3,2-c]pyrazole
Rel-2-(3-((2R,5R)-4-methoxy-5-methylpiperidin-2-yl)phenoxy)-N,N-dimethylethan-1-amine
N-ethyl-6-methyl-2-{4-[2-(4-methyl-1H-pyrazol-1-yl)ethyl]piperazin-1-yl}pyrimidin-4-amine
N-[1-(3-fluoropyridin-2-yl)piperidin-3-yl]cyclopropanesulfonamide
N-[1-(6-methylpyridin-2-yl)piperidin-3-yl]cyclopropanesulfonamide
1-(5-Bromo-3-chloropyridin-2-yl)-4-(cyclopropanesulfonyl)-1,4-diazepane

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.